These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11916282)

  • 1. The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial.
    Braga M; Walpert N; Burch HB; Solomon BL; Cooper DS
    Thyroid; 2002 Feb; 12(2):135-9. PubMed ID: 11916282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4012-6. PubMed ID: 10566642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
    Burch HB; Solomon BL; Cooper DS; Ferguson P; Walpert N; Howard R
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3016-21. PubMed ID: 11443161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy versus antithyroid medications for Graves' disease.
    Ma C; Xie J; Wang H; Li J; Chen S
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD010094. PubMed ID: 26891370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thyrotropin-receptor autoantibodies levels after I therapy in Graves' patients: effect of pretreatment with methimazole evaluated by a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    Eur J Endocrinol; 2004 Oct; 151(4):467-74. PubMed ID: 15476447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease.
    Santos RB; Romaldini JH; Ward LS
    Thyroid; 2004 Jul; 14(7):525-30. PubMed ID: 15307942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcome of 131I treatment in Graves' patients pretreated or not with methimazole.
    Pirnat E; Zaletel K; Gaberšček S; Hojker S
    Hell J Nucl Med; 2011; 14(1):25-9. PubMed ID: 21512661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of methimazole and L-thyroxine in radioiodine therapy: a prospective study on the incidence of hypothyroidism.
    Kung AW; Yau CC; Cheng AC
    Thyroid; 1995 Feb; 5(1):7-12. PubMed ID: 7787438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial.
    Bonnema SJ; Bennedbaek FN; Gram J; Veje A; Marving J; Hegedus L
    Eur J Endocrinol; 2003 Dec; 149(6):485-92. PubMed ID: 14640988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
    Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
    J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous methimazole therapy and its effect on the cure rate of hyperthyroidism using radioactive iodine: an evaluation by a randomized trial.
    Bonnema SJ; Bennedbaek FN; Veje A; Marving J; Hegedüs L
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2946-51. PubMed ID: 16735487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic 131I dose in hyperthyroidism: role of pretreatment with thionamide.
    Kabadi U; Cech R
    Thyroidology; 1994 Dec; 6(3):87-92. PubMed ID: 7545000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?
    Bogazzi F; Martino E; Bartalena L
    J Endocrinol Invest; 2003 Feb; 26(2):174-6. PubMed ID: 12739747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.